• Profile
Close

Definitive radiotherapy or chemoradiotherapy for distal rectal cancer with early stage of cT1-2N0

Cancer Management and Research Jun 14, 2019

Peng HH, et al. - In this retrospective analysis of patients treated for distal rectal cancer with stage cT1-2N0 (n=231), researchers assessed the role of definitive external beam radiotherapy or chemoradiotherapy as treatment options. Clinical complete response (cCR) was achieved by 135 patients (58.4%), for the whole group. The estimated 5-year overall survival, progression-free survival (PFS), and local recurrence-free survival were 86.19%, 83.30%, and 92.50%, respectively. Better survival was experienced by patients with cCR vs those with non-cCR. Independent predictors of PFS were clinical stage, carcinoembryonic antigen and concurrent chemotherapy, in multivariable analysis. In some early-stage distal rectal cancer, possible feasibility of definitive radiotherapy or chemoradiotherapy is suggested regarding its favorable efficacy.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay